These findings suggest that NGF control of APP phosphorylation and the subsequent events are potentially disrupted in the human AD brain where the APPpT668 level is elevated and the APP–TrkA interaction is dramatically reduced. The gene discussed is APP; the disease is Alzheimer disease.